Amanda Goldrick

620 total citations · 1 hit paper
11 papers, 245 citations indexed

About

Amanda Goldrick is a scholar working on Oncology, Hematology and Surgery. According to data from OpenAlex, Amanda Goldrick has authored 11 papers receiving a total of 245 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Oncology, 4 papers in Hematology and 2 papers in Surgery. Recurrent topics in Amanda Goldrick's work include Multiple Myeloma Research and Treatments (3 papers), Intraperitoneal and Appendiceal Malignancies (2 papers) and Ovarian cancer diagnosis and treatment (2 papers). Amanda Goldrick is often cited by papers focused on Multiple Myeloma Research and Treatments (3 papers), Intraperitoneal and Appendiceal Malignancies (2 papers) and Ovarian cancer diagnosis and treatment (2 papers). Amanda Goldrick collaborates with scholars based in Australia, United States and Spain. Amanda Goldrick's co-authors include Jeffrey C. Goh, K. Pittman, Yoland Antill, Richard H. De Boer, Melissa L. Johnson, Martin Reck, Charles M. Rudin, Gwyn Bebb, Julie M. Bailis and James Chih‐Hsin Yang and has published in prestigious journals such as Journal of Clinical Oncology, Blood and Journal of Hematology & Oncology.

In The Last Decade

Amanda Goldrick

10 papers receiving 242 citations

Hit Papers

Emerging therapies targeting the delta-like ligand 3 (DLL... 2023 2026 2024 2025 2023 25 50 75
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Emerging therapies targeting the delta-like ligand 3 (DLL3) in small cell lung cancer
    2023 89 citations Charles M. Rudin, Martin Reck et al. Journal of Hematology & Oncology profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Amanda Goldrick Australia 8 166 83 46 38 33 11 245
Hans Strauß Germany 6 85 0.5× 59 0.7× 45 1.0× 48 1.3× 40 1.2× 13 273
Şeyda Gündüz Türkiye 9 185 1.1× 31 0.4× 76 1.7× 6 0.2× 21 0.6× 15 251
Özgür Ömür Türkiye 9 49 0.3× 46 0.6× 47 1.0× 32 0.8× 20 0.6× 20 255
V. Leonardi Italy 10 188 1.1× 34 0.4× 85 1.8× 11 0.3× 4 0.1× 33 269
Aurélie Vogt United States 6 94 0.6× 96 1.2× 72 1.6× 27 0.7× 6 0.2× 12 244
Carmelo Bengala Italy 9 176 1.1× 55 0.7× 54 1.2× 103 2.7× 7 0.2× 19 320
Vasiliki Michalarea United Kingdom 7 104 0.6× 34 0.4× 54 1.2× 7 0.2× 12 0.4× 17 162
Kevin Webster United States 4 224 1.3× 94 1.1× 74 1.6× 11 0.3× 29 0.9× 6 482
Maria Koumpou Greece 8 139 0.8× 68 0.8× 126 2.7× 28 0.7× 25 0.8× 12 321
A. Caldara Italy 9 172 1.0× 52 0.6× 124 2.7× 18 0.5× 5 0.2× 26 309

Countries citing papers authored by Amanda Goldrick

Since Specialization
Citations

This map shows the geographic impact of Amanda Goldrick's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Amanda Goldrick with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Amanda Goldrick more than expected).

Fields of papers citing papers by Amanda Goldrick

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Amanda Goldrick. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Amanda Goldrick. The network helps show where Amanda Goldrick may publish in the future.

Co-authorship network of co-authors of Amanda Goldrick

This figure shows the co-authorship network connecting the top 25 collaborators of Amanda Goldrick. A scholar is included among the top collaborators of Amanda Goldrick based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Amanda Goldrick. Amanda Goldrick is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

11 of 11 papers shown
1.
Rudin, Charles M., Martin Reck, Melissa L. Johnson, et al.. (2023). Emerging therapies targeting the delta-like ligand 3 (DLL3) in small cell lung cancer. Journal of Hematology & Oncology. 16(1). 66–66. 89 indexed citations breakdown →
2.
3.
Façon, Thierry, Rubén Niesvizky, María‐Victoria Mateos, et al.. (2020). Efficacy and safety of carfilzomib-based regimens in frail patients with relapsed and/or refractory multiple myeloma. Blood Advances. 4(21). 5449–5459. 26 indexed citations
4.
5.
Mateos, María‐Victoria, Heinz Ludwig, Shaji Kumar, et al.. (2019). Safety and efficacy of once-weekly carfilzomib (K) dosing in frail patients (pts): A subgroup analysis from the phase 3 A.R.R.O.W. study.. Journal of Clinical Oncology. 37(15_suppl). 8027–8027.
6.
Pittman, K., Yoland Antill, Amanda Goldrick, Jeffrey C. Goh, & Richard H. De Boer. (2016). Denosumab: Prevention and management of hypocalcemia, osteonecrosis of the jaw and atypical fractures. Asia-Pacific Journal of Clinical Oncology. 13(4). 266–276. 46 indexed citations
7.
Kao, Steven, Mei Ling Yap, Martin Berry, et al.. (2009). Metastatic extramammary Paget's disease responding to Cisplatin, 5-Fluorouracil and radiotherapy - a case report. 1(3). 2 indexed citations
8.
Harnett, Paul R., Martin Buck, Philip Beale, et al.. (2007). Phase II study of gemcitabine and oxaliplatin in patients with recurrent ovarian cancer: an Australian and New Zealand Gynaecological Oncology Group study. International Journal of Gynecological Cancer. 17(2). 359–366. 14 indexed citations
9.
Goldrick, Amanda, Ivo A. Olivotto, Cheryl Alexander, et al.. (2007). Anemia is a Common but Neglected Complication of Adjuvant Chemotherapy for Early Breast Cancer. Current Oncology. 14(6). 227–233. 13 indexed citations
10.
Tinker, Anna V., Val Gebski, Bernard M. Fitzharris, et al.. (2006). Phase II trial of weekly docetaxel for patients with relapsed ovarian cancer who have previously received paclitaxel—ANZGOG 02-01. Gynecologic Oncology. 104(3). 647–653. 19 indexed citations
11.
Smith, Arabella, et al.. (2001). Solid variant of alveolar rhabdomyosarcoma with unbalanced t(2;13) and hypotetraploidy, without MYCN amplification. Pathology. 33(1). 108–111. 7 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Hans Strauß Breakdown of academic impact, for papers by Şeyda Gündüz Breakdown of academic impact, for papers by Özgür Ömür Breakdown of academic impact, for papers by V. Leonardi Breakdown of academic impact, for papers by Aurélie Vogt Breakdown of academic impact, for papers by Carmelo Bengala Breakdown of academic impact, for papers by Vasiliki Michalarea Breakdown of academic impact, for papers by Kevin Webster Breakdown of academic impact, for papers by Maria Koumpou Breakdown of academic impact, for papers by A. Caldara
Rankless by CCL
2026